UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth

Proceedings of the National Academy of Sciences - PNAS, 2013-05, Vol.110 (20), p.8170-8175

2013

Volltextzugriff (PDF)

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (9), p.3294-3299

2009

Volltextzugriff (PDF)

Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2

Proceedings of the National Academy of Sciences - PNAS, 2013-09, Vol.110 (38), p.15389-15394

2013

Volltextzugriff (PDF)

Synergistic Down-Regulation of Receptor Tyrosine Kinases by Combinations of mAbs: Implications for Cancer Immunotherapy

Proceedings of the National Academy of Sciences - PNAS, 2005-02, Vol.102 (6), p.1915-1920

2005

Volltextzugriff (PDF)

MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor

NMR in biomedicine, 2002-04, Vol.15 (2), p.120-131

2002

Volltextzugriff (PDF)

Multimerization of ERBB2/HER2 specific aptamer leads to improved receptor binding

Biochemical and biophysical research communications, 2015-09, Vol.465 (2), p.218-224

2015

Volltextzugriff (PDF)

Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies

Biochemical and biophysical research communications, 2019-05, Vol.513 (1), p.219-225

2019

Volltextzugriff (PDF)

On the notion of synergy of monoclonal antibodies as drugs

Communicative & integrative biology, 2009-11, Vol.2 (6), p.477-478

2009

Volltextzugriff (PDF)

Functional polymers in drug delivery: carrier-supported CDDP ( cis-platin) complexes of polycarboxylates — effect on human ovarian carcinoma

Reactive & functional polymers, 1998-02, Vol.36 (1), p.59-69

1998

Volltextzugriff (PDF)

Cancer therapeutic antibodies come of age: Targeting minimal residual disease

Molecular oncology, 2007-06, Vol.1 (1), p.42-54

2007

Volltextzugriff (PDF)

Renal accumulation of streptavidin: Potential use for targeted therapy to the kidney

Kidney international, 1995-05, Vol.47 (5), p.1327-1335

1995

Volltextzugriff (PDF)

Therapeutic vaccines: realities of today and hopes for the future

Drug Discovery Today, 2002-06, Vol.7 (12), p.664-673

2002

Volltextzugriff (PDF)

Immunoreactivities of polyclonal and monoclonal anti‐T and anti‐Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model

International journal of cancer, 1997-07, Vol.72 (1), p.119-127

1997

Volltextzugriff (PDF)

MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor: Assessing tumour vascular function using magnetic resonance imaging

NMR in biomedicine, 2002, Vol.15 (2), p.120-131

2002

Volltextzugriff (PDF)

Tissue selective affinity targeting using the avidin-biotin system

Drug development research, 2000-07, Vol.50 (3-4), p.258-271

2000

Volltextzugriff (PDF)

Preliminary toxicological studies of selected water-soluble polymer-platinum conjugates

Applied organometallic chemistry, 2000-11, Vol.14 (11), p.701-708

2000

Volltextzugriff (PDF)

Erratum: Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grownin vivo and in a xenograft model.Int. J. Cancer, 72, 119-127 (1997)

International journal of cancer, 1997-09, Vol.72 (5), p.918-918

1997

Volltextzugriff (PDF)

Erratum: Immunoreactivities of polyclonal and monoclonal anti‐T and anti‐Tn antibodies with human carcinoma cells, grown in vivo and in a xenograft model. Int. J. Cancer, 72, 119‐127 (1997)

International journal of cancer, 1997-09, Vol.72 (5), p.918-918

1997

Volltextzugriff (PDF)

Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grownin vitro and in a xenograft model

International journal of cancer, 1997-07, Vol.72 (1), p.119-127

1997

Volltextzugriff (PDF)

Tissue Selective affinity targeting using the avidin-biotin system: Drug development and biotechnology

Drug development research, 2000, Vol.50 (3-4), p.258-271

2000

Volltextzugriff (PDF)

Antibody Combining Sites to a Series of Peptide Determinants of Increasing Size and Defined Structure

The Journal of biological chemistry, 1970-03, Vol.245 (6), p.1438-1447

1970

Volltextzugriff (PDF)

Organ Selective Delivery Using a Tissue-Directed Sreptavidin-Biotin System: Targeting 5-Fluorouridine via TNP-Streptavidin

Journal of drug targeting, 1999, Vol.6 (5), p.337-348

1999

Volltextzugriff (PDF)

Effect of the dosing interval on myelotoxicity and survival in mice treated by cytarabine

European journal of cancer (1990), 1992-01, Vol.28 (6), p.1085-1090

1992

Volltextzugriff (PDF)

Tissue distribution of avidin and streptavidin injected to mice : effect of avidin carbohydrate, streptavidin truncation and exogenous biotin

European journal of biochemistry, 1990-04, Vol.189 (2), p.327-331

1990

Volltextzugriff (PDF)

Cytotoxicity of streptavidin-blocked biotinyl-ricin is retrieved by in vitro immunotargeting via biotinyl monoclonal antibody

Cancer research (Chicago, Ill.), 1992-08, Vol.52 (16), p.4448-4452

1992

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis

Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2

Synergistic Down-Regulation of Receptor Tyrosine Kinases by Combinations of mAbs: Implications for Cancer Immunotherapy

MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor

Multimerization of ERBB2/HER2 specific aptamer leads to improved receptor binding

Inhibition of a pancreatic cancer model by cooperative pairs of clinically approved and experimental antibodies

On the notion of synergy of monoclonal antibodies as drugs

Functional polymers in drug delivery: carrier-supported CDDP ( cis-platin) complexes of polycarboxylates — effect on human ovarian carcinoma

Cancer therapeutic antibodies come of age: Targeting minimal residual disease

Renal accumulation of streptavidin: Potential use for targeted therapy to the kidney

Therapeutic vaccines: realities of today and hopes for the future

Immunoreactivities of polyclonal and monoclonal anti‐T and anti‐Tn antibodies with human carcinoma cells, grown in vitro and in a xenograft model

MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor: Assessing tumour vascular function using magnetic resonance imaging

Tissue selective affinity targeting using the avidin-biotin system

Preliminary toxicological studies of selected water-soluble polymer-platinum conjugates

Erratum: Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grownin vivo and in a xenograft model.Int. J. Cancer, 72, 119-127 (1997)

Erratum: Immunoreactivities of polyclonal and monoclonal anti‐T and anti‐Tn antibodies with human carcinoma cells, grown in vivo and in a xenograft model. Int. J. Cancer, 72, 119‐127 (1997)

Immunoreactivities of polyclonal and monoclonal anti-T and anti-Tn antibodies with human carcinoma cells, grownin vitro and in a xenograft model

Tissue Selective affinity targeting using the avidin-biotin system: Drug development and biotechnology

Antibody Combining Sites to a Series of Peptide Determinants of Increasing Size and Defined Structure

Organ Selective Delivery Using a Tissue-Directed Sreptavidin-Biotin System: Targeting 5-Fluorouridine via TNP-Streptavidin

Effect of the dosing interval on myelotoxicity and survival in mice treated by cytarabine

Tissue distribution of avidin and streptavidin injected to mice : effect of avidin carbohydrate, streptavidin truncation and exogenous biotin

Cytotoxicity of streptavidin-blocked biotinyl-ricin is retrieved by in vitro immunotargeting via biotinyl monoclonal antibody

Suchergebnisse filtern